跳至主要内容
临床试验/ITMCTR2200005610
ITMCTR2200005610招募中1 期

Clinical effect of Qilian mixture on advanced lung adenocarcinoma patients with EGFR mutation of qi deficiency type and its intervention on intestinal flora

Qingdao Traditional Chinese Medicine Hospital (Haici hospital)0 个研究点开始时间: 待定最近更新:

试验速览

阶段
1 期
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
35 至 75(—)
性别
All

入选标准

  • 1. Aged 35-75 years;
  • 2. Western medicine diagnosis accords with lung adenocarcinoma stage IIIB-IV;
  • 3. Epidermal growth factor receptor (EGFR) mutation is positive;
  • 4. TCM syndrome differentiation is a patient with Qi deficiency syndrome;
  • 5. The expected survival period is more than 3 months;
  • 6. Kamofsky score >= 50 points;
  • 7. Patients were informed and signed an informed consent form voluntarily.

排除标准

  • 1. No acute gastrointestinal diseases such as abdominal pain or diarrhea occurred in the past one month;
  • 2. No history of antibiotic or probiotic use in the past 3 months;
  • 3. Did not consume yogurt in the past 7 days;
  • 4. The female is not in pregnancy or lactation period;
  • 5. Those who cannot cooperate to complete the investigation without other serious diseases, mental illness or other reasons;
  • 6. Patients who are participating in other clinical trials within the past 3 months.

研究者

发起方
Qingdao Traditional Chinese Medicine Hospital (Haici hospital)

相似试验